Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,867
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2

Xiaomeng Chena Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, China
,
Hong Mab Beijing Friendship Hospital, Capital Medical University, Beijing, China
,
Yan Gaoa Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, China
,
Ye Jina Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, China
,
Wei Ninga Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, China
,
Yue Houa Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, China
&
Jianrong Sua Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, ChinaCorrespondence[email protected]
 show all
Pages 6738-6747 | Received 02 Jun 2021, Accepted 21 Jul 2021, Published online: 13 Sep 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yichao Wang, Hang Zhao, Liying Yang, He Zhang, Xian Yu, Wenjie Fei, Yunfeng Zhen, Zhe Gao, Shuchun Chen & Luping Ren. (2022) Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice. Bioengineered 13:3, pages 6750-6766.
Read now
Lei Zou, Cuifen Shi, Dawei Wang, Juan Cheng, Qi Wang, Lei Wang & Guoya Yang. (2022) Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis. Bioengineered 13:3, pages 6150-6162.
Read now

Articles from other publishers (6)

Meysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, Behzad Hatami, Mohammad Reza Zali & Kaveh Baghaei. (2023) A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression. Pathology - Research and Practice 251, pages 154809.
Crossref
Qing Tao, Jing Xie, Yongkang Wu & Yong Jin. (2023) Long non-coding RNAs as modulators and therapeutic targets in non-alcoholic fatty liver disease (NAFLD). Gastroenterología y Hepatología.
Crossref
Na Shi, Kang Sun, Haiying Tang & Jingwei Mao. (2023) The impact and role of identified long noncoding RNAs in nonalcoholic fatty liver disease: A narrative review. Journal of Clinical Laboratory Analysis 37:11-12.
Crossref
Yuezhi Zhu, Jen Kit Tan, Sok Kuan Wong & Jo Aan Goon. (2023) Therapeutic Effects of microRNAs on Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 24:11, pages 9168.
Crossref
Jen-Yang Tang, Ya-Ting Chuang, Jun-Ping Shiau, Kun-Han Yang, Fang-Rong Chang, Ming-Feng Hou, Ammad Ahmad Farooqi & Hsueh-Wei Chang. (2022) Long Noncoding RNAs and Circular RNAs Regulate AKT and Its Effectors to Control Cell Functions of Cancer Cells. Cells 11:19, pages 2940.
Crossref
Fatemeh Kazeminasab, Maryam Baharlooie & Kamran Ghaedi. (2022) Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets. PPAR Research 2022, pages 1-13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.